IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

In The News

The HIV Prevention Pipeline | IAS 2025

Managed Healthcare Executive

July 15, 2025

Read more

In The News

Research Roundup: Sudan virus vaccine funding

Global Health Technologies Coalition

July 14, 2025

Read more

Features

IAVI receives €1 million from Dutch government for Sudan virus vaccine development

July 10, 2025

Grant supports ongoing clinical efficacy trial in Uganda in response to Sudan virus disease outbreak.

Read more

In The News

These USAID Awards Were Saving Lives. Reverse the Cuts or Reissue Them.

Center for Global Development

July 8, 2025

Read more

Videos

We are closer than ever to an HIV vaccine

July 8, 2025

Despite decades of progress in HIV prevention and treatment, millions are living with HIV as new infections continue around the world. Tools like PrEP are critical to slowing the spread of HIV, yet we are still missing one crucial piece of the puzzle: a vaccine. A safe and effective vaccine could bring a comprehensive end to the HIV pandemic by providing long-term protection, especially for those most at risk.  We sat down with Vincent Muturi-Kioi, HIV vaccines product development team lead, to discuss IAVI's recent progress toward this goal. Watch this IAVI Impact video to discover why we still need an HIV vaccine, and how sustained funding can help get us there.

Read more

Summary report: Towards a proposal for a novel TB vaccine R&D financing initiative

This report captures the key insights from a roundtable discussion, convened on 14 October 2024 at the World Health Assembly in Berlin, focused on innovative financing mechanisms to support the late-stage development of tuberculosis (TB) vaccines. The session aimed to harness expert perspectives on potential financing strategies and criteria that could be applied to TB vaccine development, with three thematic recommendations emerging.

Read more

Technical brief: Towards a proposal for a novel TB vaccine R&D financing initiative

This brief outlines key considerations and tentative recommendations towards a new financing initiative for TB vaccines R&D, with a focus on late-stage candidates. It is designed to provide background information to help stimulate debate during the workshop series on late-stage TB vaccine R&D financing R&D. The contents of this paper and the outputs of the workshop series, which includes engagement with a range of key stakeholders, will inform the development of a validated proposal for late-stage TB vaccine R&D financing.

Read more

In The News

A promising new HIV vaccine was set to start trials. Then came Trump’s latest cuts

NPR

June 10, 2025

Read more